genekor

30 November, 2022

Sanofi – Genekor collaboration for the early diagnosis of patients with rare diseases

More than 7,000 rare diseases that affect more than 300,000,000 people around the world have been identified in recent years. This fact causes the need to use particularly innovative diagnostic […]

15 September, 2022

Next Generation Sequencing (NGS) for the identification of PARP inhibitors’ predictive biomarkers

Another important study by the Genekor Scientific Team on “Next Generation Sequencing (NGS) for the identification of PARP inhibitors’ predictive biomarkers” was presented by Dr. Floros Ir. Theofanis (Oncologist Pathologist, […]

13 September, 2022

Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes

The study by the Genekor Scientific Team on “Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes” was presented at ESMO CONGRESS […]

23 August, 2022

The CureHeart Project -Team of experts from UK, US and Singapore to design jab to save thousands of lives by rewriting DNA

Cardiomyopathies are “really common” and affected one person in every 250 around the world, said Prof Hugh Watkins, from the University of Oxford and lead investigator of the CureHeart project. […]

17 August, 2022

10 tips to protect your skin from the sun.

A recent study showed that only 14% of men and 30% of women regularly put sunscreen on their face and other exposed body parts before going out for more than […]

12 July, 2022

Free genetic testing, by Genekor, for children in need of the “Agia Sofia” Children’s Cardiology Clinic

Genekor Medical S.A. in the context of social responsibility and with the aim of offering quality medical diagnostic services to all children in need, provides the Children’s Hospital “Agia Sophia”, […]

6 July, 2022

New Molecular Assay RediScore®

RediScore® is a test developed to predict the presence of HRD through the analysis of the tumor’s genomic instability. RediScore® is a test developed to predict the presence of HRD […]

11 May, 2022

Updated ASCO Guidelines!

Updated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score® Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients. ASCO® has updated its guidelines […]

28 April, 2022

Genekor Medicine SA supports “The Smile of the Child” with free genetic tests

The company Genekor Medical S.A. in the framework of social responsibility and with the aim of offering quality medical diagnostic services to all children who need support, for the year […]

Search